Evaluation index system for biomedical innovation ability system in China
DOI:
CSTR:
Author:
Affiliation:
Institute of Health Service and Transfusion Medicine, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing 100850, China
Clc Number:
Fund Project:
Article
|
Figures
|
Metrics
|
Reference
|
Related
|
Cited by
|
Materials
|
Comments
Abstract:
Objective Biomedical innovation has become the main battlefield of global science and technology competition, to explore the evaluation index system for biomedical innovation ability system, and to provide theoretical tools and new perspectives for the evaluation of biomedical innovation ability in China.Methods This article determines the key factors that affect biomedical innovation by literature investigation, Delphi expert consultation, normalization method based on expert score, principal component analysis and other methods.ResultsConclusion This article establishes an index system for biomedical innovation capability, the current status of biomedical innovation system in China was evaluated, and it was found that the policy environment, the number of researchers and the investment of R&D institutions played an important role in the development of biomedical innovation capacity in China, to provide support for enhancing China's biomedical innovation capability.